Karl Fagerström

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Management of smoking cessation in patients with psychiatric disorders
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Curr Med Res Opin 25:511-8. 2009
  2. ncbi The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data
    Karl Fagerström
    Fagerstrom Consulting AB, Kågeröd, Sweden
    Nicotine Tob Res 14:1467-73. 2012
  3. ncbi Dependence on tobacco and nicotine products: a case for product-specific assessment
    Karl Fagerström
    Fagerstrom Consulting AB, Jordkulls Gård 3670, 26878 Kagerod, Sweden
    Nicotine Tob Res 14:1382-90. 2012
  4. ncbi Snus as a smoking cessation aid: a randomized placebo-controlled trial
    Karl Fagerström
    Fagerstrom Consulting AB, Kågeröd, Sweden
    Nicotine Tob Res 14:306-12. 2012
  5. ncbi The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Nicotine Tob Res 7:343-50. 2005
  6. ncbi Neuropharmacology and potential efficacy of new treatments for tobacco dependence
    Karl Fagerström
    Smokers Information Centre and Fagerstrom Consulting, Berga Alle 1, Helsingborg, Sweden
    Expert Opin Investig Drugs 15:107-16. 2006
  7. ncbi A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries
    Karl Fagerström
    Smoker s Information Centre, Sweden
    Addiction 103:841-5. 2008
  8. ncbi Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Curr Med Res Opin 26:2165-73. 2010
  9. ncbi Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden
    BMJ 341:c6549. 2010
  10. ncbi Can reduced smoking be a way for smokers not interested in quitting to actually quit?
    Karl O Fagerstrom
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Respiration 72:216-20. 2005

Detail Information

Publications21

  1. ncbi Management of smoking cessation in patients with psychiatric disorders
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Curr Med Res Opin 25:511-8. 2009
    ....
  2. ncbi The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data
    Karl Fagerström
    Fagerstrom Consulting AB, Kågeröd, Sweden
    Nicotine Tob Res 14:1467-73. 2012
    ..We explored the relationship between the Fagerström Test for Nicotine Dependence (FTND) and smoking abstinence rates in 10 randomized, double-blind placebo-controlled Phase 2-4 varenicline studies...
  3. ncbi Dependence on tobacco and nicotine products: a case for product-specific assessment
    Karl Fagerström
    Fagerstrom Consulting AB, Jordkulls Gård 3670, 26878 Kagerod, Sweden
    Nicotine Tob Res 14:1382-90. 2012
    ..In order to capture more precisely the dependence produced by both nicotine and its administration forms, product-specific instruments may be required. The pros and cons of this approach are discussed...
  4. ncbi Snus as a smoking cessation aid: a randomized placebo-controlled trial
    Karl Fagerström
    Fagerstrom Consulting AB, Kågeröd, Sweden
    Nicotine Tob Res 14:306-12. 2012
    ..Evidence indicates that snus has been used as an effective smoking cessation aid in Scandinavia. No randomized controlled trial has directly tested the efficacy of snus for smoking cessation...
  5. ncbi The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Nicotine Tob Res 7:343-50. 2005
    ..25 mg). The cleanest nicotine products, nicotine replacement products, represent a negligible part (about 1%) of the total nicotine consumption in most countries...
  6. ncbi Neuropharmacology and potential efficacy of new treatments for tobacco dependence
    Karl Fagerström
    Smokers Information Centre and Fagerstrom Consulting, Berga Alle 1, Helsingborg, Sweden
    Expert Opin Investig Drugs 15:107-16. 2006
    ..Thus, although this approach may provide a valuable aid to smoking cessation, it seems unlikely that it can be used for primary prevention...
  7. ncbi A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries
    Karl Fagerström
    Smoker s Information Centre, Sweden
    Addiction 103:841-5. 2008
    ..To examine the correlation between the Fagerström Test for Nicotine Dependence (FTND) score and smoking prevalence across countries...
  8. ncbi Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Curr Med Res Opin 26:2165-73. 2010
    ..A pooled analysis to evaluate the efficacy and safety of varenicline versus placebo for smoking cessation in Asian populations. A secondary objective was to compare the data to pooled trials among predominantly Western populations...
  9. ncbi Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
    Karl Fagerström
    Smokers Information Centre, Fagerstrom Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden
    BMJ 341:c6549. 2010
    ..To assess the efficacy and safety of varenicline (a licensed cigarette smoking cessation aid) in helping users of smokeless tobacco to quit...
  10. ncbi Can reduced smoking be a way for smokers not interested in quitting to actually quit?
    Karl O Fagerstrom
    Smokers Information Centre, Fagerstrom Consulting AB, Helsingborg, Sweden
    Respiration 72:216-20. 2005
    ..Such an approach may bring new smokers into treatment, produce more people wanting to quit and improve public health...
  11. ncbi Smoking reduction in the management of COPD
    K Fagerstrom
    Smokers Clinic and Fagerstrom, Consulting AB, Berga Alle 1, S 25452 Helsingborg, Sweden
    Monaldi Arch Chest Dis 57:281-4. 2002
  12. ncbi Introduction: studies of tobacco dependence treatment and methodology
    Karl Olov Fagerström
    Fagerström Consulting AB and Smokers Information Center Berga Allé 1 S 254 52 Helsingborg Sweden
    Nicotine Tob Res 5:141-4. 2003
  13. ncbi From reduced smoking to quitting: improvements in COPD symptoms and lung function: a case report
    K O Fagerstrom
    Smokers Information Center and Fagerstrom Consulting, Helsingborg, Sweden
    Nicotine Tob Res 3:93-4. 2001
    ..Spirometry revealed several major improvements after reduction and abstinence...
  14. ncbi The anti-smoking climate in EU countries and Poland
    K Fagerstrom
    Smokers Information Center, Fagerstrom Consulting, Berga Alle 1, 254 52 Helsingborg, Sweden
    Lung Cancer 32:1-5. 2001
    ..The five questions chosen were--smoking is a major cause of death and disease, want to stop smoking, governments should do more, ever made a serious quit attempt and smoke free areas should be provided...
  15. ncbi Assessment of the smoker who wants to quit
    K O Fagerstrom
    Fagerstrom Consulting and Smokers Information Center, Kavalleristen 9, Berga Alle 1, 254 52 Helsingborg, Sweden
    Monaldi Arch Chest Dis 56:124-7. 2001
    ..The rationale for each assessment is given. The most important factors to assess are probably motivation, dependency and CO in expired air...
  16. ncbi Interventions for treatment-resistant smokers
    K O Fagerstrom
    Fagerström Consulting and The Smokers Information Center, Helsingborg, Sweden
    Nicotine Tob Res 1:S201-5; discussion S207-10. 1999
    ..For those who find it impossible to quit, harm-minimization procedures should definitely be invoked...
  17. ncbi The epidemiology of smoking: health consequences and benefits of cessation
    Karl Fagerström
    Fagerstrom Consulting, Kavelleristen 9, Berga Alle 1, 254 52 Helsingborg, Sweden
    Drugs 62:1-9. 2002
    ..Since smoking duration is the principal risk factor for smoking-related morbidity, the treatment goal should be early cessation and prevention of relapse...
  18. ncbi How to manage smokers in the chest unit: a motivation tailored approach
    K Fagerstrom
    Smoker Information Center, Fagerstrom Consulting AB, Berga Alle 1, S 25452 Helsingborg, Sweden
    Monaldi Arch Chest Dis 57:93-5. 2002
    ..It is presented in the form of an algorithm that gives clear practical advice what to do dependingon the smoker's motivation and past smoking history...
  19. ncbi Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review
    Karl Olov Fagerstrom
    Fagerström Consulting AB and Smokers Information Center, Helsingborg, Sweden
    Nicotine Tob Res 4:S73-9. 2002
    ..Despite substantially increased nicotine concentrations (e.g., up to 3 times the approved dose) there were no significant adverse reactions. Concurrent use of NR products and cigarette smoking appears to be safe...
  20. ncbi Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit
    K O Fagerstrom
    Smokers Information Center and Fagerstrom Consulting, Helsingborg, Sweden
    Tob Control 9:327-33. 2000
    ..The smoker's own brand of cigarette and a nicotine replacement product (Nicotrol inhaler) were used as comparisons...
  21. ncbi What is new with tobacco dependence
    Karl Fagerström
    Smokers Information Center, Helsingborg, Sweden
    Respiration 69:5-6. 2002